*Abbreviations used in this paper:* BK~Ca~ channel, large conductance calcium-activated potassium channel; Ch-T, chloramine-T; ΔG~Ca~, change in free energy change associated with Ca^2+^ binding; met-O, methionine sulfoxide; Q~app~, apparent equivalent charge movement; ROS/RNS, reactive oxygen/nitrogen species; V~0.5~, half-activation voltage; z, equivalent charge.

INTRODUCTION
============

The large conductance calcium-activated potassium channel (BK~Ca~) exists in various types of cells and tissues including smooth muscle and brain. In response to depolarization and/or a rise in intracellular Ca^2+^ (\[Ca^2+^\]~i~), BK~Ca~ channels mediate net K^+^ efflux to repolarize the membrane potential to the resting state. This function serves an important role in muscle contraction---during which Ca^2+^ sparks activate the BK~Ca~ channels leading to vasorelaxation ([@bib45]; [@bib30])---and the afterhyperpolarization phase of the action potential in select neurons ([@bib60]). Furthermore, the impairments exhibited by mice lacking the channel indicate that BK~Ca~ channels influence normal urinary bladder ([@bib44]) and cerebellar functions ([@bib56]).

The human BK~Ca~ channel pore-forming α subunit (*h*Slo1) contains seven putative transmembrane-spanning regions ([@bib17]; [@bib50]; [@bib66]). The S0 transmembrane domain, which distinguishes the *Slo* from the *Shaker* family of voltage-dependent potassium channels, is thought to be a site of interaction with auxiliary β subunits ([@bib71]; [@bib43]). Multiple types of β subunits (β1--4) have been isolated in mammals, each with a different tissue distribution and function ([@bib34]; [@bib78]; [@bib8]; [@bib68]).

The β1 subunit is a 25-kD membrane protein consisting of two transmembrane domains connected by a large extracellular loop, such that both the NH~2~ and COOH termini are intracellularly located ([@bib34]; [@bib49]; [@bib51]). The β1 subunit is present in the brain, particularly in the hippocampus and corpus callosum ([@bib67]), but is predominantly expressed in smooth muscle ([@bib21]; [@bib62]). The impaired vasorelaxation found in β1 knockout mice ([@bib9]; [@bib53]) and the down-regulation of β1 expression associated with some forms of hypertension ([@bib23]; [@bib2]; [@bib1]) clearly underscore the important physiological role of β1 in the BK~Ca~ channel regulation of vascular function. The presence of β1 modulates BK~Ca~ channel activity by enhancing the apparent Ca^2+^ sensitivity of the pore-forming subunit and also by slowing the activation/deactivation kinetics, even in the virtual absence of Ca^2+^ ([@bib41]; [@bib70]; [@bib42]; [@bib46], [@bib47]; [@bib12]; [@bib54]). The structural determinants within β1 responsible for these critical modulatory properties are just beginning to be identified ([@bib20]).

Other regulatory mechanisms such as phosphorylation, pH, and the cellular redox state influence BK~Ca~ channel activity ([@bib75]). During oxidative stress, cellular reactive oxygen/nitrogen species (ROS/RNS) readily modify cysteine and methionine residues in proteins. Oxidation of cysteine typically leads to the formation of disulfides, whereas oxidation of methionine residues creates the polar methionine sulfoxide (met-O). Oxidative modifications of amino acids differentially influence BK~Ca~ channel function depending on the ROS/RNS, the residues modified within the channel, as well as the experimental model system ([@bib16]; [@bib57]; [@bib72]; [@bib73]; [@bib6]; [@bib24]; [@bib58]; [@bib7]). Studies using heterologously expressed *h*Slo1 indicate that oxidation of cysteine residues typically decreases the channel open probability ([@bib16]; [@bib59]; [@bib64]). In contrast, methionine oxidation of the *h*Slo1 pore-forming subunit that is promoted by the oxidant chloramine-T (Ch-T) increases the channel open probability ([@bib63]).

Oxidative stress is prominently involved in many disease states such as vascular dysfunction ([@bib65]) and neurodegenerative diseases ([@bib35]; [@bib39]; [@bib10]). These physiological systems that are affected by oxidative stress depend on BK~Ca~ channel activity for normal function. Therefore, determining the effect of oxidative modification of BK~Ca~ channel complexes that closely resemble native channels is important to understand and possibly treat or prevent these diseases. Native BK~Ca~ channels are often multi-subunit complexes containing both Slo1 and auxiliary β subunits ([@bib21]; [@bib34]; [@bib22]; [@bib69]; [@bib62]; [@bib74]; [@bib76]). However, the influence of β subunits on the oxidative regulation of Slo1 function has not been thoroughly examined.

The purpose of the present work was to determine whether the presence of β1 alters the functional effects of *h*Slo1 oxidation. Methionine oxidation of *h*Slo1 alone causes a shift in the macroscopic G-V curve by −30 mV and slows deactivation without any appreciable effect on the activation kinetics at depolarized voltages ([@bib63]). We show that, in the virtual absence of Ca^2+^, the auxiliary subunit β1 dramatically potentiates the effect of methionine oxidation in the *h*Slo1 pore-forming protein. This is demonstrated by a further increase in the open probability and even greater slowing of the deactivation kinetics. Furthermore, β1 confers novel oxidation sensitivity to the channel activation kinetics that is mediated largely by a single methionine residue located in the second transmembrane domain (TM2) of β1.

MATERIALS AND METHODS
=====================

Channel Expression and Mutagenesis
----------------------------------

*h*Slo1 (U11058, hbr1; [@bib66]) channel alone, or *h*Slo1 and β1 (1:1 weight ratio) were transiently expressed in HEK-tsA cells using FuGENE 6 (Roche Applied Science) as described previously ([@bib4]). The mouse Slo β1 (*m*β1; AF020711; [@bib32]) in pEGFP-N1 (BD Biosciences) was obtained from the laboratory of R. Aldrich (Stanford University, Stanford, CA). The *m*β1 mutants M7L, M23L, M177L, and Triple (M7L:M23L:M177L) were constructed using PCR-based mutagenesis, and the sequences were verified. "Cysless" *b*β1, in which every cysteine in bovine β1 (*b*β1; L26101; [@bib34]) was replaced with alanine (C18A, C53A, C76A, C103A, and C135A; [@bib26]), was obtained from the laboratory of M.L. Garcia (Merck Research Laboratories, Rahway, NJ).

Electrophysiology and Data Analysis
-----------------------------------

Currents were recorded from excised inside-out patches at room temperature essentially as described previously ([@bib63]). Patch electrodes (Warner) had a typical initial resistance of 2.5--3 MΩ when filled with solutions (described in the next section); the series resistance, ∼90% of the input resistance, was electronically compensated. The current signal was filtered at 10 kHz through the built-in filter of the patch-clamp amplifier (model AxoPatch 200A; Axon Instruments). Data were acquired and analyzed using Pulse/PulseFit (HEKA), PatchMachine ([@bib4]), and IgorPro (WaveMetrics) as described for single-channel data ([@bib3]) and macroscopic current data ([@bib63]; [@bib4]). In brief, normalized macroscopic conductance was estimated from single exponential fits to the tail currents recorded at −50 mV excluding the initial 180 μs after pulses to different voltages from the holding voltage of 0 mV. The apparent equivalent charge movement (Q~app~) was derived from the simple Boltzmann function used to describe the average G-V curve. Activation and deactivation time courses were fitted by single exponentials excluding the initial 150- and 180-μs segments, respectively. A single exponential fit to the voltage dependence of the time constant provided the value of the equivalent charge movement (*z*).

In some patches, the tail currents after Ch-T treatment contained a minor fast component. The fractional amplitude of this component was typically small (\<10%), and the time constant estimated from single-exponential fits was essentially the same as that of the slow component estimated from two-exponential fits. Thus, single-exponential fits were used throughout to quantify the tail current kinetics. Because the time constant of the tail current before modification and that of the minor fast component after Ch-T treatment were similar, the fast component likely reflects the kinetics of unmodified channels.

The change in free energy associated with Ca^2+^ binding (ΔG~Ca~) was determined based on the ΔG~Ca~ contribution to channel open probability (*P* ~O~) as described previously ([@bib64]). The values of *P* ~O~, ΔG~o~, ΔG~V~, and ΔG~Ca~ were estimated by fitting the G-V curves obtained in 0 and 2.1 μM Ca^2+^.

Statistical comparisons were made using the paired *t* test. In some cases, the *t* test and ANOVA followed by the Bonferroni post hoc test were used as specifically indicated (DataDesk; Data Description). Statistical significance was assumed at P ≤ 0.05. Where appropriate, data are presented as mean ± SEM.

Reagents and Solutions
----------------------

Both the external and internal recording solutions contained the following (mM): 140 KCl, 11 EGTA, and 10 HEPES, pH 7.2 adjusted with NMDG. The free Ca^2+^ concentration for these solutions was estimated at \<1 nM assuming 20 μM contaminating Ca^2+^ (Patcher\'s Power Tools v1.0, F. Mendez; <http://www.mpibpc.gwdg.de/abteilungen/140/software/>). The external solution used to reduce the size of inward K^+^ currents for experiments involving 2.1 μM \[Ca^2+^\]~i~ contained the following (mM): 70 KCl, 70 NaCl, 2 MgCl~2~, and 10 HEPES, pH 7.2 adjusted with NMDG. The 2.1-μM free Ca^2+^ internal solution contained the following (mM): 120 KCl, 20 KOH, 1 MgCl~2~, 2.2 CaCl~2~, 4 HEDTA, and 10 HEPES, pH 7.4 adjusted with NMDG. The external solution used for experiments involving 120 μM \[Ca^2+^\]~i~ contained the following reagents (mM): 140 KCl, 2 MgCl~2~, and 10 HEPES, pH 7.2 adjusted with NMDG. The 120-μM free Ca^2+^ internal solution contained the following reagents (mM): 140 KCl, 10 MgCl~2~, 0.1 CaCl~2~, and 10 HEPES, pH 7.2 adjusted with NMDG.

Chloramine-T (Ch-T; Sigma-Aldrich) was dissolved in the internal solution immediately before use. In every experiment, 2 mM Ch-T was manually applied with a pipette to ensure the addition of six times the bath volume (∼150 μl). With Ch-T present, channel current in response to a pulse to 120 mV was monitored every 5 s for the following three features of oxidation by Ch-T: increased current amplitude, slowed deactivation, and accelerated activation. Once these characteristic changes reached steady-state levels (≤8 min), Ch-T was subsequently washed out with 1 ml of recording solution. The time courses of modification of channels, composed of either *h*Slo1 alone or *h*Slo1 and β1 together, were indistinguishable.

RESULTS
=======

Oxidation by Ch-T More Dramatically Enhances hSlo1 Currents When β1 Is Present
------------------------------------------------------------------------------

To determine if the presence of β1 influences the functional effects of *h*Slo1 oxidation by Ch-T, ionic currents through *h*Slo1 or *h*Slo1 + *m*β1 channels were recorded in the inside-out patch-clamp configuration from transiently transfected HEK-tsA cells. All recordings were initially made in the virtual absence of Ca^2+^, essentially permitting the Slo channel to act as a voltage-dependent channel to simplify the data analysis ([@bib42]; [@bib28]; [@bib29]). Currents elicited by pulses to 120 mV in patches containing either *h*Slo1 or *h*Slo1 + *m*β1 are shown in [Fig. 1](#fig1){ref-type="fig"} A (thin sweeps). The *h*Slo1 + *m*β1 currents displayed slow activation and deactivation (also see [Fig. 2](#fig2){ref-type="fig"}), a hallmark of the functional presence of the β1 subunit. After bath application of 2 mM Ch-T to the cytoplasmic side, *h*Slo1 and *h*Slo1 + *m*β1 exhibited similar modification time courses (P = 0.08, *t* test) that resulted in larger current amplitudes ([Fig. 1](#fig1){ref-type="fig"} A, thick sweeps). The current enhancement remained after Ch-T washout, consistent with the oxidative modification of the channel protein complex by Ch-T.

![Oxidation by Ch-T enhances *h*Slo1 + *m*β1 currents to a greater extent than *h*Slo1 currents. (A) Representative currents before (thin sweep) and after (thick sweep) 2 mM Ch-T treatment. The currents were elicited in response to pulses from 0 to 120 mV. Mean times to reach 50% of final current amplitude in the presence of Ch-T for *h*Slo1 and *h*Slo1 + *m*β1 were 5.64 ± 0.34 min and 4.68 ± 0.3 min, respectively (P = 0.08, *n* = 4). (B) Peak I-V curves before (open symbols) and after (closed symbols) modification by Ch-T. Continuous curves represent relative increases in current amplitude as a function of voltage (right axis). (C) G-V curves before (open symbols) and after (closed symbols) modification by Ch-T. The macroscopic currents were elicited by pulses to different test voltages from the holding voltage of 0 mV. The *h*Slo1 V~0.5~ values for the results obtained before and after Ch-T application were 171.9 ± 4.5 mV and 140.6 ± 6.1 mV (ΔV~0.5~ range, −19 to −42 mV; P \< 0.0001, *n* = 7), respectively. The *h*Slo1 + *m*β1 V~0.5~ values for the results obtained before and after Ch-T application were 163.8 ± 3.8 mV and 89.2 ± 4.1 mV (ΔV~0.5~ range −50 to −99 mV; P \< 0.0001, *n* = 14), respectively. The *h*Slo1 Q~app~ values for the results obtained before and after Ch-T application were 1.09 ± 0.16*e* and 0.84 ± 0.09*e* (P = 0.036, *n* = 7), respectively. The *h*Slo1 + *m*β1 Q~app~ values for the results obtained before and after Ch-T application were 0.86 ± 0.02*e* and 0.88 ± 0.04*e* , respectively, (P = 0.65, *n* = 14). (D) V~0.5~ and Q~app~ values before and after oxidation by Ch-T from individual experiments (open circles) and mean values (closed circles). (E) Representative *h*Slo1 + *m*β1 channel openings at −40 mV before and after treatment with Ch-T. Data were filtered at 10 kHz and sampled at 83 kHz, but are shown filtered at 1 kHz for display purpose. Typically, 3-min segments were analyzed in each condition.](200409144f1){#fig1}

Treatment with Ch-T shifted the peak I-V curves from both *h*Slo1 and *h*Slo1 + *m*β1 to more negative voltages, such that at a given voltage, the current size was greater ([Fig. 1](#fig1){ref-type="fig"} B). However, the current enhancement was drastically larger in *h*Slo1 + *m*β1 than in *h*Slo1 alone, especially at moderately depolarizing voltages (50--100 mV; [Fig. 1](#fig1){ref-type="fig"} B). The relative increase in current amplitude due to oxidation became progressively smaller at more depolarizing voltages where the channel open probability is saturated. This voltage dependence is consistent with Ch-T increasing the open channel probability as shown for *h*Slo1 ([@bib63]).

The voltage dependence of the probability of the channel being open inferred from normalized macroscopic G-V curves confirmed that treatment with Ch-T enhanced the open probability of *h*Slo1 + *m*β1 more profoundly than that of *h*Slo1 alone. The G-V curves estimated from tail current measurements were fit by a simple Boltzmann function as a data descriptor to describe the overall voltage dependence of the Ch-T effect ([Fig. 1](#fig1){ref-type="fig"} C). After Ch-T treatment, the *h*Slo1 half-activation voltage (V~0.5~) shifted by ∼30 mV in the hyperpolarizing direction. However, for *h*Slo1 + *m*β1, oxidation by Ch-T produced the strikingly greater shift of −75 mV. The mean shift in V~0.5~ for *h*Slo1 + *m*β1 (ΔV~0.5~ = −74.6 ± 3.5 mV, *n* = 14) was more than twice as great as ΔV~0.5~ for *h*Slo1 alone (ΔV~0.5~ = −31.3 ± 3.3 mV, *n* = 7) ([Fig. 1](#fig1){ref-type="fig"} D; *P* \< 0.0001, *t* test). These results suggest that treatment with Ch-T leads to an increase in the open probability that is markedly potentiated with *m*β1 present.

The apparent equivalent charge movement (Q~app~) of *h*Slo1 activation, inferred from the steepness of the G-V curve, decreased by ∼23% (ΔQ~app~= −0.25 ± 0.07*e*, P = 0.036, *n* = 7) after Ch-T treatment ([Fig. 1](#fig1){ref-type="fig"} D). In contrast, the ΔQ~app~ for *h*Slo1 + *m*β1 demonstrated no significant change after modification (ΔQ~app~= 0.02 ± 0.02*e*; P = 0.65, *n* = 14).

The increase in the channel open probability caused by Ch-T was maintained at more negative, physiological voltages. At −40 mV in the virtual absence of Ca^2+^, treatment with Ch-T markedly increased the number of *h*Slo1 + *m*β1 channel openings ([Fig. 1](#fig1){ref-type="fig"} E). Indeed, the mean open probability at this voltage increased by a factor of 12.0 ± 3.0 relative to control. In contrast with the dramatic changes in the gating properties of the *h*Slo1 + *m*β1 channel, the open channel current-conductance characteristic estimated using voltage ramps (0--250 mV) in single-channel patches remained unaltered by Ch-T treatment (unpublished data).

Modification by Ch-T Drastically Slows hSlo1 + mβ1 Deactivation
---------------------------------------------------------------

To assess whether treatment with Ch-T affects *h*Slo1 deactivation differently when the β1 subunit is present, *h*Slo1 and *h*Slo1 + *m*β1 tail currents were recorded before and after Ch-T treatment ([Fig. 2](#fig2){ref-type="fig"} A). After Ch-T exposure, the mean deactivation time constant at −40 mV increased by ∼70% (from 0.26 to 0.45 ms) for *h*Slo1, whereas the increase for *h*Slo1 + *m*β1 was ∼180% (from 2.12 to 6.06 ms). This appreciably greater slowing of *h*Slo1 + *m*β1 deactivation was observed at every voltage examined ([Fig. 2](#fig2){ref-type="fig"} B). Single exponential fits to the voltage dependence of the deactivation time constants in the voltage range of −150 to −50 mV indicated that oxidation by Ch-T specifically increased the time constant values at 0 mV, τ(0), for *h*Slo1 and *h*Slo1 + *m*β1 (P = 0.0021 and 0.015, respectively, *n* = 5) without significantly affecting their equivalent charge movement (P = 0.17 and 0.08, respectively, *n* = 5). In fact, the change in τ(0) for *h*Slo1 + *m*β1 is approximated by a voltage shift of −75 mV, which is similar in value to the voltage shift of the G-V curve after oxidation by Ch-T.

![Ch-T treatment slows deactivation of *h*Slo1 + *m*β1 to a greater extent than *h*Slo1 deactivation. (A) Tail currents recorded at −40 mV after pulses to 180 mV before (thin sweep) and after (thick sweep) Ch-T treatment. (B) Voltage dependence of the deactivation time constant for *h*Slo1 control (open circles; *n* = 7), *h*Slo1 after Ch-T (closed circles; *n* = 7), *h*Slo1 + *m*β1 control (open squares; *n* = 5), and *h*Slo1 + *m*β1 after Ch-T (closed squares; *n* = 5). The *h*Slo1 τ(0) and *z* values obtained before and after Ch-T application were 0.35 ± 0.04 ms and 0.19 ± 0.01*e*, and 0.63 ± 0.06 ms and 0.21 ± 0.01*e*, respectively. The *h*Slo1 + *m*β1 τ(0) and *z* values obtained before and after Ch-T application were 3.96 ± 0.52 ms and 0.38 ± 0.02*e*, and 10.9 ± 2.1 ms and 0.34 ± 0.01*e*, respectively. The relative increase in the value of the deactivation time constant as a function of voltage (right axis) is shown for *h*Slo1 (dashed line) and *h*Slo1 + *m*β1 (continuous line).](200409144f2){#fig2}

Activation Kinetics of hSlo1 + mβ1 Accelerates after Ch-T Treatment
-------------------------------------------------------------------

The activation kinetics of *h*Slo1 alone remained unaltered after modification by Ch-T ([Fig. 3](#fig3){ref-type="fig"} A; [@bib63]). In contrast, Ch-T markedly accelerated the mean activation kinetics of *h*Slo1 + *m*β1 by 68% at each voltage tested (130--240 mV; [Fig. 3](#fig3){ref-type="fig"} B). Single exponential fits to the voltage dependence of the activation time constant within this voltage range demonstrated that treatment with Ch-T decreased τ(0) for *h*Slo1 + *m*β1 (P = 0.002, *n* = 7), but not for *h*Slo1 (P = 0.23, *n* = 4), without affecting the equivalent charge movement (*h*Slo1: P = 0.14, *n* = 4; *h*Slo1 + *m*β1: P = 0.92, *n* = 7). This change in τ(0) could be accounted for by a voltage shift of more than −150 mV, which is much larger in value than the voltage shift of the G-V curve after oxidation by Ch-T.

![Modification by Ch-T accelerates activation of *h*Slo1 + *m*β1. (A) Normalized currents recorded at 240 mV from the holding voltage of 0 mV before (thin sweep) and after (thick sweep) Ch-T treatment. (B) Voltage dependence of the activation time constant for *h*Slo1 control (open circles; *n* = 7), *h*Slo1 after Ch-T (closed circles; *n* = 7), *h*Slo1 + *m*β1 control (open squares; *n* = 14), and *h*Slo1 + *m*β1 after Ch-T (closed squares; 5 ≤ *n* ≤ 12). The *h*Slo1 τ(0) and *z* values obtained before and after Ch-T application were 7.0 ± 1.2 ms and 0.28 ± 0.05*e*, and 4.4 ± 1.0 ms and 0.22 ± 0.02*e*, respectively. The *h*Slo1 + *m*β1 τ(0) and *z* values obtained before and after Ch-T application were 0.082 ± 0.01 s and 0.171 ± 0.02*e*, and 0.026 ± 0.003 s and 0.174 ± 0.02*e*, respectively.](200409144f3){#fig3}

Altogether, modification by Ch-T caused a much greater increase in *h*Slo1 open probability, an enhanced slowing of deactivation, and a distinct acceleration of activation kinetics when β1 was coexpressed. These Ch-T--induced changes specific to *h*Slo1 + *m*β1 may involve any of the following possible mechanisms. First, given that cysteine residues are also potential targets of Ch-T under physiological conditions, oxidation of cysteine within β1 may account for the enhanced oxidative regulation of *h*Slo1 + *m*β1. Second, oxidation of methionine within β1 may synergistically enhance the functional effects of *h*Slo1 oxidation. Third, the mere presence of β1 may potentiate the functional outcome of oxidation within the *h*Slo1 pore-forming subunit. These possible mechanisms are addressed in the next sections.

Cysless β1 Produces Results Similar to Wild-type β1
---------------------------------------------------

Previous results demonstrated that cysteine modification within *h*Slo1 is not involved in the Ch-T--mediated response ([@bib63]). To test whether the enhanced effects of Ch-T on channel behavior in the presence of β1 involve modification of cysteine residues within the β1 subunit, we used a mutant *b*β1 subunit devoid of any cysteine named Cysless *b*β1 ([Fig. 4](#fig4){ref-type="fig"} A; [@bib26]). Because this mutant was derived from bovine β1, we compared the results from *h*Slo1 + *b*β1 with *h*Slo1 + Cysless *b*β1.

![Cysless *b*β1 resembles wild-type *b*β1. (A) A schematic representation of cysteine residues (open circles) in *m*β1. C26 does not exist in *b*β1. Closed circles represent methionine residues. (B) Representative currents before (thin sweep) and after (thick sweep) Ch-T treatment. The currents were elicited in response to pulses from 0 to 140 mV. (C) G-V curves before and after modification by Ch-T. The *h*Slo1 + *b*β1 V~0.5~ values for the results obtained before (open circles) and after (closed circles) Ch-T application were 145.5 ± 8.2 mV and 91.4 ± 9.6 mV (ΔV~0.5~ range, −51 to −56 mV; P = 0.0009; *n* = 3), respectively. The *h*Slo1 + Cysless *b*β1 V~0.5~ values for the results obtained before (open squares) and after (closed squares) Ch-T application were 156.6 ± 4.5 mV and 98.5 ± 7.4 mV (ΔV~0.5~ range, −39 to −77 mV; P \< 0.0001, *n* = 10), respectively. The *h*Slo1 + *b*β1 Q~app~ values for the results obtained before and after Ch-T application were 0.82 ± 0.06*e* and 0.8 ± 0.04*e* (P = 0.8, *n* = 3), respectively. The *h*Slo1 + Cysless *b*β1 Q~app~ values for the results obtained before and after Ch-T application were 0.88 ± 0.03*e* and 0.74 ± 0.05*e*, respectively (P = 0.009, *n* = 10). (D) Voltage dependence of the deactivation and activation time constants. Symbols are the same as in C.](200409144f4){#fig4}

Expression of Cysless *b*β1 slowed the *h*Slo1 activation and deactivation kinetics in the control condition essentially as observed with wild-type *b*β1 ([Fig. 4](#fig4){ref-type="fig"} B), confirming that Cysless *b*β1 functionally interacts with *h*Slo1. Ch-T treatment enhanced the currents through both *h*Slo1 + *b*β1 and *h*Slo1 + Cysless *b*β1 in a similar manner. After modification by Ch-T, the *h*Slo1 + *b*β1 and *h*Slo1 + Cysless *b*β1 G-V curves shifted leftward ([Fig. 4](#fig4){ref-type="fig"} C), such that the mean ΔV~0.5~ values were indistinguishable (−54.1 ± 1.7 mV and −58.1 ± 3.6 mV, *n* = 3 and 10, respectively). Importantly, these ΔV~0.5~ values were markedly greater than those found with *h*Slo1 alone (ΔV~0.5~ ≈ −30 mV; [Fig. 1](#fig1){ref-type="fig"} D) (P \< 0.05; Bonferroni test). The ΔV~0.5~ values of *h*Slo1 + *b*β1 and *h*Slo1 + Cysless *b*β1 were smaller than that of *h*Slo1 + *m*β1 (ΔV~0.5~ ≈ −75 mV; [Fig. 1](#fig1){ref-type="fig"} D) probably because the control V~0.5~ values before treatment with Ch-T for the *b*β1 channel complexes (∼145 and 156 mV, respectively) were already less depolarized than that of *m*β1 (∼164 mV); yet, all V~0.5~ values after treatment with Ch-T were ∼90 mV. Nevertheless, the removal of all cysteine residues within the β1 subunit still permitted the enhanced ΔV~0.5~ after modification by Ch-T. Furthermore, the activation and deactivation time courses of *h*Slo1 + Cysless *b*β1 before and after treatment with the oxidant resembled those of *h*Slo1 + *b*β1 ([Fig. 4](#fig4){ref-type="fig"} D). Therefore, the kinetic and G-V results for *h*Slo1 + *m*β1, *h*Slo1 + *b*β1, and *h*Slo1 + Cysless *b*β1 are largely similar and suggest that oxidation of cysteine residues within β1 is not responsible for the enhanced oxidative regulation of *h*Slo1 in the presence of the β1 subunit.

The Greater Increase in Open Probability Does Not Depend on Methionine Oxidation within β1
------------------------------------------------------------------------------------------

The Ch-T effect on *h*Slo1 + β1 function did not involve cysteine oxidation but the oxidation of methionine residues within β1 may be responsible. Each *m*β1 contains five methionine residues: M1, M7, M23, M89, and M177 ([Fig. 5](#fig5){ref-type="fig"} A); the contribution of these methionines to the enhanced shift of the G-V curve and further slowing of deactivation, as well as acceleration of the activation kinetics was assessed in the following manner. Because M1 is obligatory for normal β1 synthesis, we could not readily test its role. M89 is present in *m*β1 but absent in *b*β1. However, both *m*β1 and *b*β1 confer to *h*Slo1 the enhanced Ch-T sensitivity, thereby excluding the critical involvement of M89 ([Fig. 4](#fig4){ref-type="fig"}). Thus, M7, M23, and M177 were individually mutated to leucine which is much less susceptible to oxidation by Ch-T than methionine ([@bib11]). In addition, a triple *m*β1 mutant ([Fig. 5](#fig5){ref-type="fig"}, Triple) in which M7, M23, and M177 were all replaced by leucine was constructed. When coexpressed with *h*Slo1, each *m*β1 mutant channel complex exhibited currents with wild-type β1-like characteristics including slower activation and deactivation compared with *h*Slo1 alone, thus confirming that these *m*β1 mutants functionally associated with *h*Slo1.

![Methionine mutations within *m*β1 permit oxidation-related increases in *h*Slo1 open probability similar to wild-type *m*β1. (A) A schematic representation of methionine residues (closed circles) in *m*β1. Open circles represent cysteine residues. (B) G-V curves before and after modification by Ch-T. The *h*Slo1 + M7L, M23L, M177L, or Triple V~0.5~ values for the results obtained before Ch-T application (open circles) were 153.9 ± 12.5 mV (*n* = 4), 147.1 ± 3.2 mV (*n* = 5), 164.1 ± 8.3 mV (*n* = 5), and 153.8 ± 6.2 mV (*n* = 6), respectively. After Ch-T application (closed circles), the *h*Slo1 + M7L, M23L, M177L, or Triple V~0.5~ values were 85.5 ± 9 mV (ΔV~0.5~ range, −54 to −78 mV; P = 0.001, *n* = 4), 96.9 ± 6.4 mV (ΔV~0.5~ range, −42 to −60 mV; P = 0.0002, *n* = 5), 105 ± 5.9 mV (ΔV~0.5~ range, −43 to −71 mV; P = 0.0005, *n* = 5), and 103.1 ± 7.3 mV (ΔV~0.5~ range, −45 to −60 mV; P \< 0.0001, *n* = 6), respectively. (C) The mean ΔV~0.5~ values (left) for *h*Slo1 + M7L, M23L, M177L, and Triple *m*β1 were −68.4 ± 5.2 mV, −50.2 ± 4.1 mV, −59.0 ± 5.8 mV, and −50.7 ± 2.6 mV, respectively. The mean ΔQ~app~ values (right) for *h*Slo1 + M7L, M23L, M177L, and Triple *m*β1 were −0.11 ± 0.03*e* (P = 0.04, *n* = 4), −0.14 ± 0.08*e* (P = 0.15, *n* = 5), −0.019 ± 0.03*e* (P = 0.6, *n* = 5), and −0.12 ± 0.04*e* (P = 0.02, *n* = 6), respectively. A negative ΔV~0.5~ indicates a leftward shift of the G-V curve, and a negative ΔQ~app~ value indicates a decrease in the slope of the G-V curve after Ch-T modification.](200409144f5){#fig5}

After modification by Ch-T, each *m*β1 mutant channel complex (M7L, M23L, M177L, and Triple) showed a large leftward shift in V~0.5~ ([Fig. 5](#fig5){ref-type="fig"} B). The mean V~0.5~ for *h*Slo1 + M7L, M23L, M177L, or Triple *m*β1 shifted by −68 ± 5.2 mV, −50 ± 4.1 mV, −59 ± 5.7 mV, and −50.6 ± 2.6 mV, respectively ([Fig. 5](#fig5){ref-type="fig"} C); these ΔV~0.5~ were significantly larger than that found with *h*Slo1 alone (ΔV~0.5~ ≈ −30 mV; [Fig. 1](#fig1){ref-type="fig"} D) (P \< 0.05, Bonferroni test). These results indicated that oxidation of methionine residues within *m*β1 is not necessary to produce the enhanced G-V curve shift after modification by Ch-T.

Methionine Oxidation within β1 Is Not Required for the Greater Slowing of hSlo1 Deactivation
--------------------------------------------------------------------------------------------

Treatment with Ch-T slowed the deactivation time course of every *h*Slo1+ mutant *m*β1 complex examined ([Fig. 6](#fig6){ref-type="fig"} A). The extent of this slowing of *h*Slo1 deactivation with any of the *m*β1 mutants was indistinguishable from the slowing of *h*Slo1 + *m*β1 ([Fig. 6](#fig6){ref-type="fig"} B). The voltage dependence of the deactivation kinetics was also unaltered by Ch-T treatment with the equivalent charge movement remaining at ∼0.3*e* in all cases. Thus, the Ch-T--induced slowing of channel deactivation did not specifically require M7, M23, M177, or the presence of all three residues together in β1.

![Slowing of channel deactivation after oxidation by Ch-T is maintained in all *m*β1 methionine mutant channel complexes. (A) Superimposed *h*Slo1 + M7L, M23L, M177L, or Triple *m*β1 normalized tail currents recorded at −40 mV after pulses to 180 mV before (thin sweeps) and after (thick sweeps) treatment with Ch-T. (B) Voltage dependence of the deactivation time constant for *h*Slo1 + wild type (diamonds; *n* = 5), M7L (circles; *n* = 4), M23L (triangles; *n* = 5), M177L (squares; *n* = 5), or Triple (inverted triangles; *n* = 6) *m*β1 before (open symbols) and after (closed symbols) Ch-T treatment.](200409144f6){#fig6}

M177 in mβ1 Is Critical for Typical hSlo1 Activation Properties
---------------------------------------------------------------

Oxidative modification by Ch-T accelerated the activation kinetics of *h*Slo1 + *m*β1 but not of *h*Slo1 alone ([Fig. 3](#fig3){ref-type="fig"}). For channel complexes that included an *m*β1 methionine point mutant, there was a trend for the activation kinetics to be faster than *h*Slo1+ wild-type *m*β1 even before Ch-T treatment ([Fig. 7](#fig7){ref-type="fig"} A). However, a difference in the activation time course was statistically significant only in *h*Slo1 + M177L *m*β1 (220 mV; P = 0.002, Bonferroni test). In fact, the activation kinetics of *h*Slo1 + M177L *m*β1 before Ch-T treatment was similar to that of the *h*Slo1+ wild-type *m*β1 complex after modification by Ch-T.

![M177 in *m*β1 specifically affects channel activation. (A) Voltage dependence of the activation time constant before treatment with Ch-T for *h*Slo1 + wild type (diamonds; *n* = 14), M7L (circles; *n* = 4), M23L (triangles; *n* = 5), or M177L (squares; *n* = 5) *m*β1. (B) Currents recorded at 220 mV from the holding voltage of 0 mV before (thin sweep) and after (thick sweep) modification by Ch-T. (C) Activation time constant values at 220 mV before and after oxidation by Ch-T from individual experiments.](200409144f7){#fig7}

The activation kinetics of *h*Slo1 + M7L *m*β1 and *h*Slo1 + M23L *m*β1 after Ch-T treatment were significantly faster, as found with wild-type *m*β1 ([Fig. 7, B and C](#fig7){ref-type="fig"}; P = 0.005 and 0.03, respectively). However, Ch-T failed to accelerate the activation time course of *h*Slo1 + M177L *m*β1 in an appreciable manner (P ≥ 0.085). M177L *m*β1 does associate with *h*Slo1 because the deactivation kinetics of *h*Slo1 + M177L *m*β1 was indistinguishable from *h*Slo1 + *m*β1 ([Fig. 6](#fig6){ref-type="fig"} B). Thus, M177 in TM2 of β1 is a key determinant of the activation kinetics and the oxidative sensitivity of *h*Slo1 + *m*β1.

The Effect of Ch-T Treatment with β1 Present Is Ca^2+^ Dependent
----------------------------------------------------------------

The hyperpolarizing shift in V~0.5~ caused by treatment with Ch-T was essentially eliminated by increasing \[Ca^2+^\]~i~ to 2.1 μM ([Fig. 8](#fig8){ref-type="fig"} A). Similar results were obtained with saturating levels of divalent ions, \[Ca^2+^\]~i~ = 120 μM and \[Mg^2+^\]~i~ = 10 mM ([Fig. 8](#fig8){ref-type="fig"} B). In the presence of elevated \[Ca^2+^\]~i~, cysteine oxidation is capable of shifting the G-V curve to the right ([@bib64]), which may account for the depolarizing shift seen here after treatment with Ch-T. With the assumption that the free energy changes associated with the BK~Ca~ channel intrinsic opening process, voltage-dependent activation, and Ca^2+^ binding together contribute to the overall open probability in a linearly additive manner ([@bib15]), the measured G-V parameters were used to infer the free energy contributions of Ca^2+^ to channel opening ([@bib64]) in the control and Ch-T treated conditions. The decrease in ΔG~Ca~ (∼50%) after Ch-T modification of *h*Slo1 + *m*β1 in 2.1 μM \[Ca^2+^\]~i~ indicates that Ca^2+^ makes a smaller free energy contribution to overall channel opening after oxidation ([Fig. 8](#fig8){ref-type="fig"} A, inset).

![The effect of Ch-T on channel open probability depends on Ca^2+^. (A) G-V curves before and after modification by Ch-T. Currents were first generated by pulsing to different test potentials from a holding voltage of 0 mV in the virtual absence of Ca^2+^. This recording protocol was repeated after bath application of 2.1 μM Ca^2+^. Tail currents were measured at −50 mV in zero \[Ca^2+^\]~i~ or −100 mV in high \[Ca^2+^\]~i~. After a return to zero Ca^2+^ for treatment with 2 mM Ch-T, the recording protocol was again repeated in zero and then 2.1 μM Ca^2+^. The zero \[Ca^2+^\]~i~ V~0.5~ values for the results obtained before (open circles) and after (closed circles) Ch-T application were 155.3 ± 5.1 mV and 103.5 ± 7.2 mV (ΔV~0.5~ range, −47 to −56 mV; P = 0.002, *n* = 3), respectively. The smaller ΔV~0.5~ value (approximately −50 vs. −75 mV; [Fig. 1](#fig1){ref-type="fig"}) was most likely because of the use of an external recording solution containing less K^+^ than that previously used in the zero \[Ca^2+^\]~i~ experiments. The 2.1 μM \[Ca^2+^\]~i~ V~0.5~ values for the results obtained before (open squares) and after (closed squares) Ch-T application were 9.1 ± 11.2 mV and 29.6 ± 12.5 mV (ΔV~0.5~ range, 15--25 mV; P = 0.018, *n* = 3), respectively. The zero \[Ca^2+^\]~i~ Q~app~ values for the results obtained before and after Ch-T application were 0.84 ± 0.04*e* and 0.79 ± 0.02*e* (P = 0.13, *n* = 3), respectively. The 2.1 μM \[Ca^2+^\]~i~ Q~app~ values for the results obtained before and after Ch-T application were 1.03 ± 0.07*e* and 0.88 ± 0.03*e* (P = 0.1, *n* = 3), respectively. (inset) The contribution of Ca^2+^-dependent gating to overall channel opening (ΔG~Ca~) before and after oxidation by Ch-T from individual experiments. (B) Representative currents from a single patch (*n* = 5) in the presence of 120 μM \[Ca^2+^\]~i~ before (thin sweeps) and after (thick sweeps) Ch-T treatment. The currents were elicited from a holding voltage of −200 mV.](200409144f8){#fig8}

Biophysical Model Simulation
----------------------------

The functional effects of oxidation by Ch-T of the *h*Slo1 + β1 complex in the virtual absence of Ca^2+^ may be interpreted using the HCA allosteric gating model ([Fig. 9](#fig9){ref-type="fig"} A; [@bib29]) as performed for the *h*Slo1 channel without β1 ([@bib63]). The voltage dependence of *h*Slo1 alone shifts by −30 mV, and the deactivation time course slows after oxidation by Ch-T. To account for these alterations, [@bib63] increased the value of the strongly voltage-dependent parameter α(0), which may correspond to movement of the voltage sensor ([@bib29]), by 2.3-fold and decreased the rate constant of the closing transition dominant at negative voltages (γ~0~) by 60% ([Fig. 9](#fig9){ref-type="fig"} B; [@bib63], Fig. 14). We simulated the potentiated effects of Ch-T treatment in the presence of β1 in the following manner. First, the value of α(0) is further increased (about twofold) to account for the larger shift, −75 mV, of the G-V curve ([Fig. 9](#fig9){ref-type="fig"} B). Second, the closing rate constant γ~0~ decreases by an additional 40% to account for the greater slowing of the tail kinetics. Third, in addition to the two quantitative changes listed, the rate constant for the opening transition dominant at positive voltages (δ~4~) is increased by 2.1-fold to account for the unique acceleration of the activation kinetics observed in *h*Slo1 + β1 but not in *h*Slo1 alone. Simulated data produced from this model that account for the effect of Ch-T on *h*Slo1 function with β1 present match the experimental data ([Fig. 9](#fig9){ref-type="fig"}, C--E).

![Simulation of oxidation by Ch-T on *h*Slo1 + β1 function based on the HCA model. (A) The HCA allosteric gating model ([@bib29]). The most probable opening of the channel at strongly depolarized voltages involves transitions from C~0~ to C~1~, C~2~, C~3~, C~4~, and then O~4~. Likewise, channel closing at negative voltages entails transitions from O~4~ to O~3~, O~2~, O~1~, O~0~, and then C~0~. (B) Adjustments in average parameter values from the HCA model required to simulate the effect of modification by Ch-T on *h*Slo1 ([@bib63]) or *h*Slo1 + β1 function. HCA model values are as follows: α(0) = 1,500 s^−1^, β(0) = 35,370 s^−1^, δ~0~(0) = 0.007 s^−1^, δ~1~(0) = 0.154 s^−1^, δ~2~(0) = 3.39 s^−1^, δ~3~(0) = 52 s^−1^, δ~4~(0) = 65 s^−1^, *D* = 22, *f* = *D* ^0.5^, and *L*(0) = δ~0~(0)/γ~0~(0) = 2 × 10^−6^. *L*(0) represents the open-to-closed equilibrium constant in the absence of an applied voltage. (C) Experimental *h*Slo1 + *m*β1 currents (continuous sweeps) recorded at 160 mV before (thin) and after (thick) oxidation by Ch-T and simulated currents (dashed lines) from the HCA model adjusted for the effect of Ch-T in the presence of β1. (D) G-V curves from a patch containing *h*Slo1 + *m*β1 before (open circles) and after (closed circles) treatment with Ch-T. Data simulated from the *h*Slo1 + β1 model before (dotted line) and after (continuous line) Ch-T are superimposed. (E) Activation/deactivation time constants. Symbols are the same as in D.](200409144f9){#fig9}

DISCUSSION
==========

Methionine Oxidation Leads to Distinct Alterations in hSlo1 + β1 Function
-------------------------------------------------------------------------

Coexpression of β1 with *h*Slo1 is known to affect the activation/deactivation kinetics and apparent Ca^2+^ sensitivity of the channel ([@bib49]). Here, we have demonstrated that oxidation of *h*Slo1 in the presence of the auxiliary subunit β1 leads to functional effects clearly distinguishable from those observed with *h*Slo1 alone. Oxidation of *h*Slo1 promoted by Ch-T causes a leftward shift of the G-V curve by ∼30 mV. However, this hyperpolarizing shift is more than twice as great (∼75 mV) in the presence of β1. Furthermore, the Ch-T--induced slowing of *h*Slo1 deactivation is even more dramatic with β1 present. In addition, β1 confers a novel effect of oxidation not observed with *h*Slo1 alone; modification by Ch-T leads to the distinct acceleration of *h*Slo1 activation evident at each depolarized voltage only with the inclusion of β1 into the channel complex. These unique features of oxidative modification in the presence of the β1 subunit overall cannot be accounted for by a difference in the modification rate as compared with *h*Slo1 alone or a simple voltage-dependent shift in the open probability and activation/deactivation kinetics.

Role of Cysteine and Methionine Residues in β1
----------------------------------------------

Because Ch-T preferentially oxidizes methionine residues under physiological conditions ([@bib38]), methionine is implicated as the main target of oxidation by Ch-T that is responsible for the observed functional alterations in both *h*Slo1 and *h*Slo1 + β1. However, protein-modifying agents may not be perfectly specific for one particular amino acid. In fact, both cysteine and methionine are possible physiological targets of Ch-T. To determine if cysteine oxidation plays a role in the Ch-T effect on *h*Slo1 alone, [@bib63] previously showed that cysteine-specific reagents (5,5′-dithio-bis (2-nitrobenzoic acid), methanethiosulfonate ethylammonium, and *p*-chloromercuribenzoic acid) actually decreased channel activity, thereby demonstrating that cysteine oxidation has opposite effects on channel function than methionine oxidation. Furthermore, the Ch-T--induced potentiation was maintained in *h*Slo1 mutants that lacked most of the cysteine residues within the channel. Finally, peptide methionine sulfoxide reductase, an enzyme that catalyzes the reduction of met-O ([@bib77]), partially reversed the effect of Ch-T treatment. Therefore, the functional alterations caused by Ch-T were attributed to methionine oxidation within *h*Slo1.

Cysteine residues within β1 are not required for typical regulation of *h*Slo1 kinetics or the enhanced effects on channel function after oxidation. The *b*β1 subunit devoid of any cysteine residues behaves much like wild-type *b*β1 in terms of slowing *h*Slo1 activation and deactivation. Furthermore, after oxidation by Ch-T, the cysteine mutations still permit the significantly larger ΔV~0.5~ value, the slower deactivation kinetics and the accelerated channel activation similar to those observed with wild-type *b*β1. These results indicate that cysteine is not the likely Ch-T target responsible for causing the functional changes after oxidation.

Similar to the *b*β1 cysteine mutant, the *m*β1 methionine mutants regulate *h*Slo1 kinetics much like wild-type β1. Moreover, all *m*β1 methionine mutants including the triple mutant maintain the dramatic shift of the G-V curve toward the hyperpolarizing direction and the enhanced slowing of channel deactivation after oxidation by Ch-T. Evaluation of the role of the initial β1 methionine residue (M1) is not straightforward. However, its contribution to the enhanced oxidative regulation of *h*Slo1, although a possibility, is unlikely due to potential removal by posttranslational processing of the mature protein ([@bib14]). Therefore, the presence of the β1 subunit provides the possibility to amplify the functional effects of methionine oxidation within the *h*Slo1 pore-forming subunit with regard to channel open probability and deactivation.

β1 M177 Involvement in the Functional Interaction with Slo1
-----------------------------------------------------------

Although the enhanced shift of the G-V curve and slowing of *h*Slo1 deactivation does not require cysteine or methionine residues within β1, the effect of oxidation on *h*Slo1 activation critically depends on M177 in TM2 of *m*β1. In the control condition, only M177L *m*β1 causes a significant difference in the channel activation time course. Furthermore, the M177L mutation eliminates the oxidative sensitivity of channel activation typically observed with β1 present. Thus, M177 controls the *h*Slo1 activation kinetics at very positive voltages, which is described by the rate constant δ~4~ in the HCA model ([Fig. 9](#fig9){ref-type="fig"}), and oxidation of M177 to met-O most likely mediates the Ch-T--induced acceleration of activation kinetics. However, the possibility that the M177L mutation hinders the access of Ch-T to its target elsewhere cannot be completely eliminated.

The mutant-specific effect on channel activation suggests a partial uncoupling of *h*Slo1 and β1 because of mutation or oxidation at the M177 position. Because the activation kinetics of *h*Slo1 is faster without β1, oxidation of *h*Slo1 + β1 may cause channel activation to be more like *h*Slo1 alone by removal of the β1 influence. The hydrophobic leucine mutation at M177 mimics the presence of met-O at that location because the control activation kinetics of *h*Slo1 + M177L *m*β1 resembles that of oxidized *h*Slo1+ wild-type *m*β1. Indeed, an increase in surface hydrophobicity, while somewhat paradoxical, has been shown after oxidation of methionine residues within the enzyme glutamine synthetase ([@bib38]). Perhaps oxidation of M177 to met-O, whereby acting as the sensor or switch, partially disrupts an interaction between the β1 subunit and the structural elements in or near the RCK (regulator of K^+^ conductance) domains within *h*Slo1 that are specifically responsible for controlling activation kinetics. Similar to the effect of β1 M177 on channel activation, other residues within different β subunits influence functional coupling of the auxiliary subunit and *h*Slo1. For example, the phosphorylation states of T11/S17 in the cytoplasmic NH~2~ terminus and S210 in the cytoplasmic COOH terminus within β4 affect the functional coupling between *h*Slo1 and β4, as determined by changes in channel voltage dependence and activation/deactivation kinetics specific to modification of the different residues ([@bib33]).

Physiological Implications
--------------------------

As found with *h*Slo1 alone, the effect of methionine oxidation on *h*Slo1 function in the presence of β1 is sensitive to \[Ca^2+^\]~i~. In the virtual absence of \[Ca^2+^\]~i~, *h*Slo1 + *m*β1 displays a hyperpolarizing shift of V~0.5~ that is twice as great as *h*Slo1 alone after oxidation by Ch-T. This Ch-T--induced shift resembles the presence of ∼0.4 μM \[Ca^2+^\]~i~ ([@bib12]). The oxidized channel complex can open in the physiological voltage range (\<50 mV) without \[Ca^2+^\]~i~ as further evidenced by the increase in open probability observed at −40 mV. An increase in channel open probability at low \[Ca^2+^\]~i~ could have an impact on resting BK~Ca~ channel activity in smooth muscle cells, thereby influencing vascular tone. Because BK~Ca~ channels crucially shape the action potential posthyperpolarization phase in certain cell types, this increase in channel open probability may prevent unregulated neuronal firing ([@bib37]; [@bib60]; [@bib40]; [@bib80]; [@bib52]; [@bib19]; [@bib18]).

The concept that the binding of Ca^2+^ performs mechanical work to open the Slo1 channel ([@bib31]) has been further developed into a spring-based gating mechanism in which the diameter of the gating ring, formed by the RCK domains from each Slo1 subunit, expands upon Ca^2+^ binding, thereby generating an active force that pulls the S6-RCK1 linker regions that act as the springs, thus opening the channel gates ([@bib48]). This proposed gating process might be similarly affected by methionine oxidation, which biases the open channel state. In the absence of \[Ca^2+^\]~i~, oxidation of methionine residues to met-O within the *h*Slo1 pore-forming subunit may likewise affect the structure or position of the gating ring ultimately influencing gating of the channel. The lack of a hyperpolarizing shift of V~0.5~ in response to modification by Ch-T at high \[Ca^2+^\]~i~ indicates that the effects of Ca^2+^ and methionine oxidation on channel gating are not additive and may in fact operate on the same effectors. In the case of the *h*Slo1 + β1 channel complex, the presence of β1 may cause a unique conformational change in *h*Slo1, such that additional methionine residues in *h*Slo1 are exposed and able to react with Ch-T, thereby accounting for the enhanced functional effects of oxidation. However, the similarity in the modification time courses of *h*Slo1 and *h*Slo1 + *m*β1 argues against this possibility.

Modification of ion channels by ROS/RNS during oxidative stress could alter channel function and eventually disrupt normal \[Ca^2+^\]~i~ and other homeostatic parameters ([@bib36]). Potential consequences of oxidative stress include accelerated aging ([@bib27]), as well as pathophysiological conditions such as various neurodegenerative disorders ([@bib13]) and ischemia-reperfusion injury after stroke ([@bib5]; [@bib55]). However, certain ion channel modifications by ROS/RNS may serve as compensatory mechanisms to oxidative assault. One such example involves the mitochondrial ATP-sensitive K^+^ channel (mitoK~ATP~) that is activated by ROS during initial, mild ischemia; as a result, the heart is preconditioned to future ischemic attacks and infarctions ([@bib61]; [@bib25]; [@bib79]). Much like the mitoK~ATP~ channel, the BK~Ca~ channel clearly represents a prime candidate for aiding in the recovery from ROS/RNS attack given its localization in brain and smooth muscle, as well as the documented oxidation-related alteration of its function ([@bib16]; [@bib57]; [@bib72]; [@bib73]; [@bib6]; [@bib24]; [@bib58]; [@bib63], [@bib64]; [@bib7]). Whether the BK~Ca~ channel contributes to the progression of oxidative stress-related conditions or instead serves a more compensatory role---such as maintaining resting membrane potential if \[Ca^2+^\]~i~ is disrupted---remains to be determined.

In summary, we showed that in the virtual absence of Ca^2+^, methionine oxidation by Ch-T dramatically alters *h*Slo1 function with the association of the β1 subunit. The presence of β1 as opposed to methionine and/or cysteine oxidation within this auxiliary subunit greatly amplifies the increase in channel open probability and the slowing of deactivation derived from oxidation of the *h*Slo1 pore-forming subunit. The target methionine residues within *h*Slo1 are not yet known, but may be found in the S5/P/S6 segments ([@bib63]) and/or the gating ring region ([@bib48]). In contrast, M177 within β1 influences *h*Slo1 activation and most likely serves as the methionine target responsible for the acceleration in channel activation after methionine oxidation in the presence of the β1 subunit. Testing the oxidative effects with β subunits present provides more relevant results that can then be readily extended to physiological or pathophysiological conditions. Whether the effect of methionine oxidation on *h*Slo function in the presence of other β subunits (β2--4) also occurs remains to be determined, but β1 clearly facilitates unique modulation of channel function in the face of oxidation.
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